González-Muñoz Sara, Cerván-Martín Miriam, Guzmán-Jiménez Andrea, Rodríguez-Martín Ana Isabel, Garrido Nicolás, Castilla José A, Gonzalvo M Carmen, Clavero Ana, Molina Marta, Vilches Miguel Ángel, Espuch-Oliver Andrea, Maldonado Vicente, García-Peña María Luisa, Galiano-Gutiérrez Noelia, Santamaría Esther, González Cristina, Quintana-Ferraz Fernando, Gómez Susana, Amorós David, Martínez-Granados Luis, Ortega-González Yanira, Burgos Miguel, Pereira-Caetano Iris, Pinto Graça S, Aguiar Ana, Pereira Isabel S, López-Rodrigo Olga, Bassas Lluís, Seixas Susana, Gonzçalves João, Lopes Alexandra M, Larriba Sara, Bossini-Castillo Lara, Carmona F David, Palomino-Morales Rogelio J
Departamento de Genética e Instituto de Biotecnología, Centro de Investigación Biomédica (CIBM), Universidad de Granada, Granada, Spain.
Instituto de Investigación Biosanitaria, ibs.GRANADA, Granada, Spain.
Hum Reprod. 2025 Jun 11. doi: 10.1093/humrep/deaf107.
What is the functional impact of the rs508485 genetic polymorphism, located in the 3'-untranslated region (UTR) region of the PIWIL4 gene, on non-obstructive azoospermia (NOA)?
The rs508485 genetic variant contributes to the pathogenesis of extreme patterns of NOA by modulating PIWIL4 expression through microRNA (miRNA) interactions.
Male infertility represents a significant global health challenge with profound societal and economic consequences. One of the most severe forms of male infertility is NOA, which is characterized by severe spermatogenic failure (SPGF) of idiopathic origin in most cases. Cumulating knowledge increasingly suggests that this idiopathic form of NOA may represent a multifactorial condition involving complex interactions between genetic and environmental factors. The PIWI protein subfamily, particularly PIWIL4, plays a pivotal role in spermatogenesis by processing PIWI-interacting RNAs, which silence retrotransposons to protect genomic integrity. Genetic variations in this gene have been found to be associated with susceptibility to NOA.
STUDY DESIGN, SIZE, DURATION: A case-control study was conducted in a European cohort including 1516 infertile men with SPGF and 2451 fertile controls. Logistic regression and functional assays were employed to investigate the functional role of the rs508485 polymorphism in PIWIL4.
PARTICIPANTS/MATERIALS, SETTING, METHODS: Participants were genotyped for the rs508485 polymorphism. Associations between the polymorphism and NOA phenotypes, including Sertoli cell-only (SCO) syndrome and testicular sperm extraction (TESE) outcomes, were assessed. In silico tools predicted miRNA binding effects, which were subsequently validated using luciferase reporter assays.
The T allele of rs508485 was significantly associated with the SCO phenotype (P = 2.69E-03, OR = 1.34) and unfavourable TESE outcomes (P = 1.09E-03, OR = 1.54). In silico analyses predicted that the rs508485 variant might alter binding sites in the 3'-UTR region of PIWIL4 for different miRNAs, such as hsa-miR-215-3p and hsa-miR-136-3p. Functional validation using luciferase assays confirmed that these miRNAs differentially bind to the T and C alleles of this polymorphism, influencing PIWIL4 regulation.
N/A.
LIMITATIONS, REASONS FOR CAUTION: The study is limited to a single genetic polymorphism and functional assays were performed in vitro. Additional studies are required to validate these findings across diverse populations and explore additional genetic interactions.
These findings highlight the critical role of miRNA regulation in extreme forms of male infertility by influencing the expression of essential spermatogenesis genes, such as PIWIL4. Our study sheds light on the genetic mechanisms underlying spermatogenesis and suggests potential therapeutic targets for NOA.
STUDY FUNDING/COMPETING INTEREST(S): This work was supported by the Spanish Ministry of Economy and Competitiveness through the Spanish National Plan for Scientific and Technical Research and Innovation (grant: PID2020-120157RB-I00 funded by MICIU/AEI/10.13039/501100011033; and grant: PID2023-152215OB-I00 funded by MICIU/AEI/10.13039/501100011033 and ERDF, EU). M.C.-M is beneficiary of a Juan de la Cierva 2022 postdoctoral fellowship (reference number JDC2022-048561-I) funded by MCIN/AEI/10.13039/501100011033 and European Union NextGenerationEU/PRTR. S.L. received support from "Generalitat de Catalunya" (grant 2021SGR052). S.L. is sponsored by the "Researchers Consolidation Program" from the SNS-Dpt. Salut Generalitat de Catalunya (Exp. CES09/020). S.G.-M. was funded by grant ref. FPU23/02674. S.S. was supported by funds from the Portuguese Foundation for Science and Technology (FCT; 10.54499/DL57/2016/CP1363/CT0019). The authors declare no competing interests.
位于PIWIL4基因3'非翻译区(UTR)的rs508485基因多态性对非梗阻性无精子症(NOA)有何功能影响?
rs508485基因变异通过与微小RNA(miRNA)相互作用调节PIWIL4表达,从而促成NOA极端类型的发病机制。
男性不育是一项重大的全球健康挑战,具有深远的社会和经济影响。男性不育最严重的形式之一是NOA,在大多数情况下,其特征是特发性严重生精功能衰竭(SPGF)。越来越多的知识表明,这种特发性NOA形式可能是一种多因素疾病,涉及遗传和环境因素之间的复杂相互作用。PIWI蛋白亚家族,尤其是PIWIL4,通过加工PIWI相互作用RNA在精子发生中起关键作用,这些RNA使逆转座子沉默以保护基因组完整性。已发现该基因的遗传变异与NOA易感性有关。
研究设计、规模、持续时间:在一个欧洲队列中进行了一项病例对照研究,包括1516名患有SPGF的不育男性和2451名生育对照。采用逻辑回归和功能测定来研究rs508485多态性在PIWIL4中的功能作用。
参与者/材料、环境、方法:对参与者进行rs508485多态性基因分型。评估该多态性与NOA表型之间的关联,包括唯支持细胞(SCO)综合征和睾丸精子提取(TESE)结果。计算机工具预测miRNA结合效应,随后使用荧光素酶报告基因测定进行验证。
rs508485的T等位基因与SCO表型显著相关(P = 2.69E - 03,OR = 1.34)和不利的TESE结果(P = 1.09E - 03,OR = 1.54)。计算机分析预测,rs508485变异可能会改变PIWIL4的3'-UTR区域中不同miRNA(如hsa-miR-215-3p和hsa-miR-136-3p)的结合位点。使用荧光素酶测定进行的功能验证证实,这些miRNA与该多态性的T和C等位基因差异结合,影响PIWIL4的调控。
无。
局限性、谨慎原因:该研究仅限于单一基因多态性,且功能测定是在体外进行的。需要进一步研究以在不同人群中验证这些发现,并探索其他遗传相互作用。
这些发现突出了miRNA调控通过影响精子发生关键基因(如PIWIL4)的表达在极端形式男性不育中的关键作用。我们的研究揭示了精子发生的遗传机制,并为NOA提出了潜在的治疗靶点。
研究资金/利益冲突:这项工作得到了西班牙经济与竞争力部通过西班牙国家科学技术研究与创新计划的支持(资助:PID2020 - 120157RB - I00,由MICIU/AEI/10.13039/501100011033资助;以及资助:PID2023 - 152215OB - I00,由MICIU/AEI/10.13039/501100011033和欧盟区域发展基金资助)。M.C.-M是由MCIN/AEI/10.13039/501100011033和欧盟下一代欧盟/PRTR资助的2022年胡安·德拉·西尔瓦博士后奖学金(参考编号JDC2022 - 048561 - I)的受益者。S.L.获得了“加泰罗尼亚自治区”的支持(资助2021SGR052)。S.L.由加泰罗尼亚卫生署SNS - Dpt.的“研究人员巩固计划”赞助(实验编号CES09/020)。S.G.-M.由资助编号FPU23/02674资助。S.S.得到了葡萄牙科学技术基金会(FCT;10.54499/DL57/2016/CP1363/CT0019)的资金支持。作者声明无利益冲突。